Trials that matter: The effect of a fixed-dose combination of an angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes

被引:1
作者
Bakris, George L. [2 ]
Berkwits, Michael [1 ]
机构
[1] Amer Coll Physicians, Philadelphia, PA 19106 USA
[2] Univ Chicago, Chicago, IL 60637 USA
关键词
D O I
10.7326/0003-4819-148-5-200803040-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:400 / W86
页数:4
相关论文
共 20 条
[1]  
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[2]   Executive summary: Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S5-S11
[3]   Differences in glucose tolerance between fixed-dose anti hypertensive drug combinations in people with metabolic syndrome [J].
Bakris, George ;
Molitch, Mark ;
Hewkin, Ann ;
Kipnes, Mark ;
Sarafidis, Pantelis ;
Fakouhi, Kaffa ;
Bacher, Peter ;
Sowers, James .
DIABETES CARE, 2006, 29 (12) :2592-2597
[4]   Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[5]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[6]   Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial [J].
Cushman, William C. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Evans, Gregory W. ;
Capes, Sarah ;
Corson, Marshall A. ;
Sadler, Laurie S. ;
Alderman, Michael H. ;
Peterson, Kevin ;
Bertoni, Alain ;
Basile, Jan N. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) :44I-55I
[7]   Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents [J].
Gerbino, Philip P. ;
Shoheiber, Omar .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (12) :1279-1283
[8]  
Gerstein HC, 2000, LANCET, V355, P253
[9]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[10]   Exceptional early blood pressure control rates: The ACCOMPLISH trial [J].
Jamerson, Kenneth ;
Bakris, George L. ;
Dahlof, Bjorn ;
Pitt, Bertram ;
Velazquez, Eric ;
Gupte, Jitendra ;
Lefkowitz, Martin ;
Hester, Allen ;
Shi, Victor ;
Kjeldsen, Sverre E. ;
Cushman, William ;
Papademetriou, Vasilios ;
Weber, Michael .
BLOOD PRESSURE, 2007, 16 (02) :80-86